In the case of interleukin-8 (IL-8), a compound that acts as a survival factor for cancer cells and contributes to cancer metastasis, proliferation, and angiogenesis, inhibiting IL-8 is valuable in cancer therapy. Here, CXCL8 is linked to cancer.